Home - Chinese Journal of Cancer Research

2020 Impact Factor of CJCR: 5.087
Journal Citation Reports®, Clarivate Analytics

National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version)

National Health Commission of the People’s Republic of China

Cancer burden and trends in China: A review and comparison with Japan and South Korea

Cancer is the leading cause of death worldwide. Distinct geographic disparities exist in cancer burden across the world. China, Japan, and South Korea are all located in East Asia. As neighboring countries, Japan and South Korea share similar genetic backgrounds and similar culture with China. Also, in terms of cancer burden, these three countries are all facing a heavy burden of upper digestive tract cancers. This article provides an overview of cancer burden and trends in China by comparing with Japan and South Korea. Comparison among these three countries for the cancer burden and trends could be useful to track the effectiveness of national screening programs and to identify modifiable risk factors. The results can serve as a scientific reference for cancer control policy planning.

Cancer incidence and mortality in China, 2014

In 2017, National Central Cancer Registry of China (NCCRC) updated nationwide cancer statistics using population-based cancer registry data in 2014 collected from all available cancer registries. There are 449 cancer registries submitted cancer registry data in 2014, among which 339 registries’ data met the criteria of quality control and were included in analysis. These cancer registries covered 288,243,347 population, accounting for about 21.07% of the national population in 2014. Numbers of nationwide new cancer cases and deaths were estimated using calculated incidence and mortality rates and corresponding national population stratified by area, sex, age group and cancer type. The world Segi’s population was applied for age-standardized rates. Heavy cancer burden and its disparities between area, sex and age group pose a major challenge to public health in China. Nationwide cancer registry plays a crucial role in cancer prevention and control.

Cancer incidence in Beijing, 2014

To analyze cancer incidence data in Beijing in 2014 and temporal trends for selected common cancers during 2005 and 2014. A total of 144 secondary and tertiary hospitals reported newly diagnosed cancer cases to Beijing Cancer Registry, which covers 13 million residents in Beijing. The cancer incidence rate was calculated in strata by cancer type, sex, age group and area. The population composition of China in 1982 and Segi’s population structure were used to calculate age-standardized rates. Extensive procedures were used to assure the quality of the data. A total of 45,300 new cancer cases were diagnosed in Beijing in 2014. The incidence rate was 341.92/100,000 (343.50/100,000 in males, 340.33/100,000 in females). Cancer remains an important public health problem. Actions should be taken to diminish total cancer incidence in Beijing.

‹ ›

Vol 33, No 3 (June 2021)

Original Article

Textbook Outcome as a measure of surgical quality assessment and prognosis in gastric neuroendocrine carcinoma: A large multicenter sample analysis

Qiyue Chen, Zhongliang Ning, Zhiyu Liu, Yanbing Zhou, Qingliang He, Yantao Tian, Hankun Hao, Wei Lin, Lixin Jiang, Gang Zhao, Ping Li, Chaohui Zheng, Changming Huang, on behalf of the Study Group for Gastric Neuroendocrine Tumors

Pages: 433-446 HTML

Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy

Ning Li, Xin Wang, Yuan Tang, Dongbin Zhao, Yihebali Chi, Lin Yang, Liming Jiang, Jun Jiang, Jinming Shi, Wenyang Liu, Hua Ren, Hui Fang, Yu Tang, Bo Chen, Ningning Lu, Hao Jing, Shunan Qi, Shulian Wang, Yueping Liu, Yongwen Song, Yexiong Li, Jing Jin

Pages: 447-456 HTML

Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis

Hao Hu, Chang Qu, Bingjun Tang, Weikang Liu, Yongsu Ma, Yiran Chen, Xuehai Xie, Yan Zhuang, Hongqiao Gao, Xiaodong Tian, Yinmo Yang

Pages: 457-469 HTML

Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts

Jianyong Zhuo, Di Lu, Jianguo Wang, Zhengxing Lian, Jiali Zhang, Huihui Li, Beini Cen, Xuyong Wei, Qiang Wei, Haiyang Xie, Xiao Xu

Pages: 470-479 HTML

Attributable deaths of liver cancer in China

Maomao Cao, Chao Ding, Changfa Xia, He Li, Dianqin Sun, Siyi He, Wanqing Chen

Pages: 480-489 HTML

Efficacy and safety of chemotherapy combined with bevacizumab in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, observational, non-interventional phase IV trial

Fenghua Wang, Guanghai Dai, Yanhong Deng, Yong Tang, Wei Wang, Zuoxing Niu, Feng Bi, Liangjun Zhu, Zengqing Guo, Jin Yan, Bing Hu, Min Tao, Shujun Yang, Suzhan Zhang, Lu Wen, Ruihua Xu

Pages: 490-499 HTML

Features of colorectal cancer in China stratified by anatomic sites: A hospital-based study conducted in university-affiliated hospitals from 2014 to 2018

Ruize Qu, Yanpeng Ma, Liyuan Tao, Xiaoyuan Bao, Xin Zhou, Bingyan Wang, Fei Li, Siyi Lu, Lin Tuo, Siyan Zhan, Zhipeng Zhang, Wei Fu

Pages: 500-511 HTML

Comparative yield and efficiency of strategies based on risk assessment and fecal immunochemical test in colorectal cancer screening: A cross-sectional population-based analysis

Hongda Chen, Le Wang, Ming Lu, Chen Zhu, Yunfeng Zhu, Weihua Ma, Xinmin Chen, Lingbin Du, Wanqing Chen

Pages: 512-521 HTML

Review Article

Advances in novel molecular typing and precise treatment strategies for small cell lung cancer

Rilan Bai, Lingyu Li, Xiao Chen, Yuguang Zhao, Wei Song, Huimin Tian, Jiuwei Cui

Pages: 522-534 HTML

Guidelines

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)

Jun Zhu, Jun Ma, Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology

Pages: 289-301 HTML

Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020

Caixia Dong, Yuwei Ding, Shanshan Weng, Guichao Li, Yanqing Huang, Hanguang Hu, Zhen Zhang, Suzhan Zhang, Ying Yuan

Pages: 302-307 HTML

Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor

Jian Li, Yingjiang Ye, Jian Wang, Bo Zhang, Shukui Qin, Yingqiang Shi, Yulong He, Xiaobo Liang, Xiufeng Liu, Ye Zhou, Xin Wu, Xinhua Zhang, Ming Wang, Zhidong Gao, Tianlong Lin, Hui Cao, Lin Shen, Chinese Society of Clinical Oncology (CSCO) Expert Committee on Gastrointestinal Stromal Tumor

Pages: 281-293 HTML

NHCPRC Guidelines

National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version)

National Health Commission of the People’s Republic of China

Pages: 415-445 HTML

Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 707-737 HTML

Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 578-585 HTML

Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 557-577 HTML

Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 223-258 HTML

Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 259-277 HTML

Chinese guidelines for diagnosis and treatment of pancreatic cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 278-294 HTML

Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 295-305 HTML

Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 1-28 HTML

Chinese guidelines for diagnosis and treatment of renal cell carcinoma 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 29-48 HTML

Chinese guidelines for diagnosis and treatment of urothelial carcinoma of bladder 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 49-66 HTML

Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 67-83 HTML

CSCO Guidelines

Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019

Shanshan Weng, Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 403-407 HTML

Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018

Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 423-425 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer working group

Pages: 84-98 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer working group

Pages: 99-116 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer working group

2020 Impact Factor of CJCR: 5.087Journal Citation Reports®, Clarivate Analytics

National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version)

Cancer burden and trends in China: A review and comparison with Japan and South Korea

Cancer incidence and mortality in China, 2014

Cancer incidence in Beijing, 2014

About cjcr

Advertising

Contact us

Original Article

Review Article

Guidelines

NHCPRC Guidelines

CSCO Guidelines

Virtual Special Issues

Beijing Cancer Hospital

China Anti-cancer Association

Chronic Diseases and Translational Medicine

2018 CGCC

2020 Impact Factor of CJCR: 5.087
Journal Citation Reports®, Clarivate Analytics